s20098 has been researched along with Bipolar Disorder in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baus, C; Dogui, R; Kennel, J; Riemenschneider, M; Siebert, S | 1 |
| Norman, TR; Olver, JS | 1 |
| Delmonte, D; Smeraldi, E | 1 |
| Nance, M; Pannell, J; Thorpe, M | 1 |
| Campanella, D; De Bartolomeis, A; De Berardis, D; Di Giannantonio, M; Di Nicola, M; Fornaro, M; Iasevoli, F; Martinotti, G; Mazza, M; Olivieri, L; Perna, G; Rapini, G; Serroni, N; Srinivasan, V; Tomasetti, C; Valchera, A | 1 |
| Bucci, N; Perugi, G; Quaranta, G | 1 |
| Bourin, M; Calabrese, J; de Bodinat, C; Goodwin, GM; Laredo, J; Vieta, E; Yatham, LN | 1 |
| Abreu, T; Bragança, M | 1 |
| Eppel, AB | 1 |
| Green, B | 1 |
| Coogan, AN; Thome, J | 1 |
| Smirnova, VN; Tiuvina, NA | 1 |
| Calabrese, JR; Gao, K | 1 |
| Calabrese, JR; Guelfi, JD; Perdrizet-Chevallier, C | 1 |
8 review(s) available for s20098 and Bipolar Disorder
| Article | Year |
|---|---|
Agomelatine for depression: expanding the horizons?
Topics: Acetamides; Antidepressive Agents; Bipolar Disorder; Circadian Rhythm; Depression; Diabetes Mellitus, Type 2; Humans; Hypnotics and Sedatives; Seasonal Affective Disorder; Serotonin Antagonists | 2019 |
Agomelatine in depression.
Topics: Acetamides; Animals; Antidepressive Agents; Bipolar Disorder; Depressive Disorder, Major; Humans; Melatonin; Serotonin 5-HT2 Receptor Antagonists; Treatment Outcome | 2013 |
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression.
Topics: Acetamides; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Fibromyalgia; Humans; Migraine Disorders; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Receptor, Serotonin, 5-HT2C; Schizophrenia; Sleep Wake Disorders | 2015 |
The use of agomelatine in OCD: effects on the motivational aspects and dysregulated circadian rhythms.
Topics: Acetamides; Animals; Bipolar Disorder; Chronobiology Disorders; Humans; Hypnotics and Sedatives; Motivation; Obsessive-Compulsive Disorder; Sleep Wake Disorders; Treatment Outcome | 2015 |
The bipolarity of light and dark: A review on Bipolar Disorder and circadian cycles.
Topics: Acetamides; Affect; Antimanic Agents; Bipolar Disorder; Circadian Rhythm; Humans; Hypnotics and Sedatives; Light; Lithium Carbonate; Melatonin; Phototherapy; Sleep; Sleep Deprivation | 2015 |
Focus on agomelatine.
Topics: Acetamides; Adult; Animals; Antidepressive Agents; Anxiety; Bipolar Disorder; Depression; Dose-Response Relationship, Drug; Humans; Hypnotics and Sedatives; Models, Biological; Sleep; Treatment Outcome | 2011 |
Chronotherapeutics and psychiatry: setting the clock to relieve the symptoms.
Topics: Acetamides; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Brain; Chronobiology Disorders; Chronotherapy; Circadian Rhythm; Depressive Disorder; Depressive Disorder, Major; Humans; Mental Disorders; Seasonal Affective Disorder | 2011 |
Newer treatment studies for bipolar depression.
Topics: Acetamides; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Dopamine Agonists; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Lamotrigine; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Secondary Prevention; Transcranial Magnetic Stimulation; Triazines | 2005 |
2 trial(s) available for s20098 and Bipolar Disorder
| Article | Year |
|---|---|
Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: randomised double-blind placebo-controlled trial.
Topics: Acetamides; Adult; Antidepressive Agents; Antimanic Agents; Argentina; Australia; Bipolar Disorder; Brazil; Canada; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Humans; India; International Cooperation; Lithium Compounds; Male; Middle Aged; Placebo Effect; Psychiatric Status Rating Scales; Republic of Korea; South Africa; Treatment Outcome; Valproic Acid | 2016 |
Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data.
Topics: Acetamides; Adult; Aged; Antimanic Agents; Bipolar Disorder; Depressive Disorder; Female; Humans; Lithium Compounds; Male; Middle Aged; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome; Valproic Acid | 2007 |
4 other study(ies) available for s20098 and Bipolar Disorder
| Article | Year |
|---|---|
Agomelatine-Related Shift to Mania in a Patient With Recurrent Depressive Disorder.
Topics: Acetamides; Adult; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Female; Humans; Recurrence | 2017 |
Agomelatine-associated manic switch in bipolar depression: a case report.
Topics: Acetamides; Adult; Antidepressive Agents; Bipolar Disorder; Female; Humans; Melatonin | 2014 |
Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data.
Topics: Acetamides; Acute Disease; Bipolar Disorder; Humans; Hypnotics and Sedatives | 2008 |
[A comparative evaluation of the efficacy of valdoxan (agomelatine) in recurrent depression and bipolar affective disorder].
Topics: Acetamides; Adult; Antidepressive Agents; Bipolar Disorder; Circadian Rhythm; Depressive Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychometrics; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Recurrence; Serotonin 5-HT2 Receptor Antagonists; Treatment Outcome | 2012 |